94 related articles for article (PubMed ID: 7681287)
1. [Comparative studies on the immunoactive action of galactoside-specific mistletoe lectin. Pure substance compared to the standardized extract].
Beuth J; Ko HL; Tunggal L; Geisel J; Pulverer G
Arzneimittelforschung; 1993 Feb; 43(2):166-9. PubMed ID: 7681287
[TBL] [Abstract][Full Text] [Related]
2. [Immunoactive effects of various mistletoe lectin-1 dosages in mammary carcinoma patients].
Beuth J; Stoffel B; Ko HL; Buss G; Tunggal L; Pulverer G
Arzneimittelforschung; 1995 Apr; 45(4):505-7. PubMed ID: 7779151
[TBL] [Abstract][Full Text] [Related]
3. Mistletoe extract standardized for the galactoside-specific lectin (ML-1) induces beta-endorphin release and immunopotentiation in breast cancer patients.
Heiny BM; Beuth J
Anticancer Res; 1994; 14(3B):1339-42. PubMed ID: 8067703
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulating ability of galactoside-specific lectin standardized and depleted mistletoe extract.
Beuth J; Stoffel B; Ko HL; Jeljaszewicz J; Pulverer G
Arzneimittelforschung; 1995 Nov; 45(11):1240-2. PubMed ID: 8929248
[TBL] [Abstract][Full Text] [Related]
5. Correlation of immune cell activities and beta-endorphin release in breast carcinoma patients treated with galactose-specific lectin standardized mistletoe extract.
Heiny BM; Albrecht V; Beuth J
Anticancer Res; 1998; 18(1B):583-6. PubMed ID: 9568181
[TBL] [Abstract][Full Text] [Related]
6. [Effect of mistletoe lectin therapy on serum level of defined serum proteins (acute phase proteins) in tumor patients].
Beuth J; Gabius HJ; Steuer MK; Geisel J; Steuer M; Ko HL; Pulverer G
Med Klin (Munich); 1993 May; 88(5):287-90. PubMed ID: 7687001
[TBL] [Abstract][Full Text] [Related]
7. Thymocyte proliferation and maturation in response to galactoside-specific mistletoe lectin-1.
Beuth J; Ko HL; Tunggal L; Steuer MK; Geisel J; Jeljaszewicz J; Pulverer G
In Vivo; 1993; 7(5):407-10. PubMed ID: 8110981
[TBL] [Abstract][Full Text] [Related]
8. [Immunoactive action of mistletoe lectin-1 in relation to dose].
Beuth J; Ko HL; Tunggal L; Buss G; Jeljaszewicz J; Steuer MK; Pulverer G
Arzneimittelforschung; 1994 Nov; 44(11):1255-8. PubMed ID: 7848341
[TBL] [Abstract][Full Text] [Related]
9. Behavior of lymphocyte subsets and expression of activation markers in response to immunotherapy with galactoside-specific lectin from mistletoe in breast cancer patients.
Beuth J; Ko HL; Gabius HJ; Burrichter H; Oette K; Pulverer G
Clin Investig; 1992 Aug; 70(8):658-61. PubMed ID: 1392440
[TBL] [Abstract][Full Text] [Related]
10. Immunoprotective activity of the galactoside-specific mistletoe lectin in cortisone-treated BALB/c-mice.
Beuth J; Ko HL; Tunggal L; Buss G; Jeljaszewicz J; Steuer MK; Pulverer G
In Vivo; 1994; 8(6):989-92. PubMed ID: 7772751
[TBL] [Abstract][Full Text] [Related]
11. From ill-defined extracts to the immunomodulatory lectin: will there be a reason for oncological application of mistletoe?
Gabius HJ; Gabius S; Joshi SS; Koch B; Schroeder M; Manzke WM; Westerhausen M
Planta Med; 1994 Feb; 60(1):2-7. PubMed ID: 8134410
[TBL] [Abstract][Full Text] [Related]
12. Modulatory potency of the beta-galactoside-specific lectin from mistletoe extract (Iscador) on the host defense system in vivo in rabbits and patients.
Hajto T; Hostanska K; Gabius HJ
Cancer Res; 1989 Sep; 49(17):4803-8. PubMed ID: 2758413
[TBL] [Abstract][Full Text] [Related]
13. Immunoprotective activity of the galactoside-specific lectin from mistletoe after tumor destructive therapy in glioma patients.
Lenartz D; Stoffel B; Menzel J; Beuth J
Anticancer Res; 1996; 16(6B):3799-802. PubMed ID: 9042260
[TBL] [Abstract][Full Text] [Related]
14. Cellular immunomodulation and safety of standardized aqueous mistletoe extract PS76A2 in tumor patients treated for 48 weeks.
Dohmen W; Breier M; Mengs U
Anticancer Res; 2004; 24(2C):1231-7. PubMed ID: 15154652
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulating efficacy of combined administration of galactoside-specific lectin standardized mistletoe extract and sodium selenite in BALB/c-mice.
Stoffel B; Krämer K; Mayer H; Beuth J
Anticancer Res; 1997; 17(3C):1893-6. PubMed ID: 9216641
[TBL] [Abstract][Full Text] [Related]
16. Modulation of cellular and humoral immune responses during exposure of healthy individuals to an aqueous mistletoe extract.
Stein GM; Berg PA
Eur J Med Res; 1998 Jun; 3(6):307-14. PubMed ID: 9620894
[TBL] [Abstract][Full Text] [Related]
17. Further refinement of the description of the ligand-binding characteristics for the galactoside-binding mistletoe lectin, a plant agglutinin with immunomodulatory potency.
Galanina OE; Kaltner H; Khraltsova LS; Bovin NV; Gabius HJ
J Mol Recognit; 1997; 10(3):139-47. PubMed ID: 9408830
[TBL] [Abstract][Full Text] [Related]
18. Influence of treatment with the immunomodulatory effective dose of the beta-galactoside-specific lectin from mistletoe on tumor colonization in BALB/c-mice for two experimental model systems.
Beuth J; Ko HL; Gabius HJ; Pulverer G
In Vivo; 1991; 5(1):29-32. PubMed ID: 1932621
[TBL] [Abstract][Full Text] [Related]
19. Modulating activity of mistletoe lectins 1 and 2 on the lymphatic system in BALB/c-mice.
Beuth J; Stoffel B; Samtleben R; Staak O; Ko HL; Pulverer G; Wagner H
Phytomedicine; 1996 Jan; 2(3):269-73. PubMed ID: 23194628
[TBL] [Abstract][Full Text] [Related]
20. A natural immunity-activating plant lectin, Viscum album agglutinin-I, induces apoptosis in human lymphocytes, monocytes, monocytic THP-1 cells and murine thymocytes.
Hostanska K; Hajto T; Weber K; Fischer J; Lentzen H; Sütterlin B; Saller R
Nat Immun; 1996-1997; 15(6):295-311. PubMed ID: 9523281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
